Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 8Phase 1/2 1

Status

Completed 4Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 2NETWORK 1

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 8

Conditions

Prostatic Neoplasms 48Breast Neoplasms 8Neoplasms 4Leiomyoma 3Breast Neoplasms, Male 2Sexual Dysfunction, Physiological 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Myofibroma 1Breast Cancer Invasive 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1Adenocarcinoma 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Leuprolide × Clear all
NCT05827081 2026-06-03

Adjuvant WIDER

Novartis

Phase 3 Recruiting
1,400 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02344472 2024-06-04

Detect V / CHEVENDO (Chemo vs. Endo)

University of Ulm

Phase 3 Active not recruiting
271 enrolled
Breast

Breast Neoplasms

NCT02941926 2023-10-24

COMPLEEMENT-1

Novartis

Phase 3 Completed
3,246 enrolled 11 charts
Breast

Breast Neoplasms

NCT02914158 2023-01-17

ASPAIT

First Affiliated Hospital, Sun Yat-Sen University

Phase 3 Unknown
680 enrolled
Breast

Breast Neoplasms

NCT02980965 2017-11-13

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Fudan University

Phase 3 Completed
249 enrolled
Breast

Breast Neoplasms

NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,000 enrolled
Breast

Breast Neoplasms

NCT00002582 2013-08-02

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
6,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡